Quantum-Si (NASDAQ:QSI) is preparing to release its quarterly earnings on Tuesday, 2026-03-03. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Quantum-Si to report an earnings per share (EPS) of $-0.13.

Investors in Quantum-Si are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Overview of Past Earnings

The company's EPS missed by $0.03 in the last quarter, leading to a 8.33% drop in the share price on the following day.

Here's a look at Quantum-Si's past performance and the resulting price change:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	-0.14	-0.14	-0.14	-0.19
EPS Actual	-0.17	-0.16	-0.11	-0.23
Price Change %	-8.33	-4.86	0.00	6.15

Tracking Quantum-Si's Stock Performance

Shares of Quantum-Si were trading at $0.9564 as of February 27. Over the last 52-week period, shares are down 31.48%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

Get to Know Quantum-Si Better

Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.

Financial Insights: Quantum-Si

Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.

Revenue Challenges: Quantum-Si's revenue growth over 3 months faced difficulties. As of 30 September, 2025, the company experienced a decline of approximately -29.86%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.

Net Margin: Quantum-Si's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -6467.93%, the company may face hurdles in effective cost management.

Return on Equity (ROE): Quantum-Si's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -15.65% ROE, the company effectively utilizes shareholder equity capital.

Return on Assets (ROA): Quantum-Si's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -13.88%, the company may face hurdles in achieving optimal financial returns.

Debt Management: With a below-average debt-to-equity ratio of 0.02, Quantum-Si adopts a prudent financial strategy, indicating a balanced approach to debt management.

To track all earnings releases for Quantum-Si visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.